Fundraising Fox
Combat
2 known investors
Find your way into Combat
Sign up to see every warm intro you have to Combat
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Combat team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
Founders & leadership
EB
Edward Bruce-WhiteCEO/Co-FounderEdward Bruce-White is CEO and co-founder of Combatcancer, a clinical-stage cancer treatment company developing therapies for bladder and prostate cancer. He brings over 20 years of experience in medical device product development, commercialization, and business strategy, with a background that includes managing major corporate transactions, IPOs, and M&A activities.
AM
Alberto Martinez AlbalatDirector of R&D, Founder and Chairman
Investors · 2
Frequently asked questions
- What does Combat do?
- Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
- Who founded Combat?
- Combat was founded by Edward Bruce-White, Alberto Martinez Albalat.
- Who are Combat's investors?
- Combat's investors include Oxford Technology Management, NW Angel.